Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Expands Roche and AstraZeneca Partnerships

Premium

PALO ALTO, Calif.--Incyte Pharmaceuticals announced the expansion and extension of its agreements with Hoffmann-La Roche and AstraZeneca, continuing deals that were originally signed in 1996. AstraZeneca's expanded arrangement will include access to Incyte's LifeSeq Gold database of human gene sequence and expression data, its ZooSeq animal model database, and additional genomic databases and services. The Roche agreement grants access to LifeSeq Gold, ZooSeq, and continued access to the LifeSeq Atlas mapping database in exchange for annual access fees. In addition, Incyte could receive future milestone payments and royalties on sales of products developed with Incyte technology and database information. Financial terms for both agreements were not disclosed. The combination of the ZooSeq and the LifeSeq Gold databases enable scientists to make comparisons between human and animal pathways, Incyte said.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.